Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-10116-01470
Entry Name
UniProt Accession
Theoretical PI
6.63
Molecular Weight
68746.24
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Sodium-dependent dopamine transporter
Protein Synonyms/Alias
DA transporter; DAT; Solute carrier family 6 member 3;
Gene Name
Slc6a3
Gene Synonyms/Alias
Created Date
01-MAR-1992
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
580
Canonical
IYATYKFCSLPGSFR
[1]
S-Palmitoylation
Organism
Rattus norvegicus (Rat)
NCBI Taxa ID
10116
Reference
[1] Foster JD, Vaughan RA. Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation. J Biol Chem. 2011 Feb18;286(7):5175-86. doi: 10.1074/jbc.M110.187872. Epub 2010 Nov 30.[PMID:21118819]
Functional Description
Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals.
Sequence Annotation
Topological domain: 1 68 Cytoplasmic.
Transmembrane: 69 89 Helical; Name=1.
Transmembrane: 96 116 Helical; Name=2.
Transmembrane: 140 160 Helical; Name=3.
Topological domain: 161 236 Extracellular.
Transmembrane: 237 255 Helical; Name=4.
Transmembrane: 264 281 Helical; Name=5.
Transmembrane: 317 334 Helical; Name=6.
Transmembrane: 346 367 Helical; Name=7.
Transmembrane: 400 419 Helical; Name=8.
Transmembrane: 446 464 Helical; Name=9.
Transmembrane: 480 500 Helical; Name=10.
Transmembrane: 521 540 Helical; Name=11.
Transmembrane: 559 577 Helical; Name=12.
Topological domain: 578 619 Cytoplasmic.
Region: 560 589 Interaction with TGFB1I1.
Protein Length
619 AA.
Protein Sequence
(Canonical)
MSKSKCSVGP MSSVVAPAKE SNAVGPREVE LILVKEQNGV QLTNSTLINP PQTPVEAQER  60
ETWSKKIDFL LSVIGFAVDL ANVWRFPYLC YKNGGGAFLV PYLLFMVIAG MPLFYMELAL  120
GQFNREGAAG VWKICPVLKG VGFTVILISF YVGFFYNVII AWALHYFFSS FTMDLPWIHC  180
NNTWNSPNCS DAHASNSSDG LGLNDTFGTT PAAEYFERGV LHLHQSRGID DLGPPRWQLT  240
ACLVLVIVLL YFSLWKGVKT SGKVVWITAT MPYVVLTALL LRGVTLPGAM DGIRAYLSVD  300
FYRLCEASVW IDAATQVCFS LGVGFGVLIA FSSYNKFTNN CYRDAIITTS INSLTSFSSG  360
FVVFSFLGYM AQKHNVPIRD VATDGPGLIF IIYPEAIATL PLSSAWAAVF FLMLLTLGID  420
SAMGGMESVI TGLVDEFQLL HRHRELFTLG IVLATFLLSL FCVTNGGIYV FTLLDHFAAG  480
TSILFGVLIE AIGVAWFYGV QQFSDDIKQM TGQRPNLYWR LCWKLVSPCF LLYVVVVSIV  540
TFRPPHYGAY IFPDWANALG WIIATSSMAM VPIYATYKFC SLPGSFREKL AYAITPEKDH  600
QLVDRGEVRQ FTLRHWLLL                                               619
FASTA
(Canonical)
>LipidDB-10116-01470|P23977
MSKSKCSVGPMSSVVAPAKESNAVGPREVELILVKEQNGVQLTNSTLINPPQTPVEAQER
ETWSKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELAL
GQFNREGAAGVWKICPVLKGVGFTVILISFYVGFFYNVIIAWALHYFFSSFTMDLPWIHC
NNTWNSPNCSDAHASNSSDGLGLNDTFGTTPAAEYFERGVLHLHQSRGIDDLGPPRWQLT
ACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAMDGIRAYLSVD
FYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIITTSINSLTSFSSG
FVVFSFLGYMAQKHNVPIRDVATDGPGLIFIIYPEAIATLPLSSAWAAVFFLMLLTLGID
SAMGGMESVITGLVDEFQLLHRHRELFTLGIVLATFLLSLFCVTNGGIYVFTLLDHFAAG
TSILFGVLIEAIGVAWFYGVQQFSDDIKQMTGQRPNLYWRLCWKLVSPCFLLYVVVVSIV
TFRPPHYGAYIFPDWANALGWIIATSSMAMVPIYATYKFCSLPGSFREKLAYAITPEKDH
QLVDRGEVRQFTLRHWLLL
Gene Ontology
GO:0030424; C:axon; IEA:Ensembl
GO:0005887; C:integral component of plasma membrane; IEA:InterPro
GO:0043005; C:neuron projection; IDA:RGD
GO:0043025; C:neuronal cell body; IEA:Ensembl
GO:0005886; C:plasma membrane; IDA:RGD
GO:0035240; F:dopamine binding; IEA:Ensembl
GO:0005329; F:dopamine transmembrane transporter activity; IDA:RGD
GO:0005330; F:dopamine:sodium symporter activity; IDA:RGD
GO:0008144; F:drug binding; IDA:RGD
GO:0002020; F:protease binding; IPI:RGD
GO:0032403; F:protein complex binding; IDA:RGD
GO:0051721; F:protein phosphatase 2A binding; IPI:RGD
GO:0005102; F:receptor binding; IPI:RGD
GO:0021984; P:adenohypophysis development; IEA:Ensembl
GO:0007568; P:aging; IEP:RGD
GO:0098655; P:cation transmembrane transport; IDA:GOC
GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl
GO:0042420; P:dopamine catabolic process; IEA:Ensembl
GO:0015872; P:dopamine transport; IDA:RGD
GO:0007595; P:lactation; IEA:Ensembl
GO:0007626; P:locomotory behavior; IEA:Ensembl
GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
GO:0060134; P:prepulse inhibition; IEA:Ensembl
GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl
GO:0051591; P:response to cAMP; IDA:RGD
GO:0042220; P:response to cocaine; IEA:Ensembl
GO:0042493; P:response to drug; IEP:RGD
GO:0045471; P:response to ethanol; IDA:RGD
GO:0010039; P:response to iron ion; IEP:RGD
GO:0035094; P:response to nicotine; IEP:RGD
GO:0014070; P:response to organic cyclic compound; IEP:RGD
GO:0007608; P:sensory perception of smell; IEA:Ensembl
Interpro
InterPro; IPR000175; Na/ntran_symport
InterPro; IPR002436; Na/ntran_symport_dopamine
Pfam
Pfam; PF00209; SNF;
SMART
PROSITE
PROSITE; PS00610; NA_NEUROTRAN_SYMP_1;
PROSITE; PS00754; NA_NEUROTRAN_SYMP_2;
PROSITE; PS50267; NA_NEUROTRAN_SYMP_3;
PRINTS
PRINTS; PR01202; DOPTRANSPORT;
PRINTS; PR00176; NANEUSMPORT;